Showing results (31-40 of 60) with videos related to
Sort By:
Pageof 6
The Journal of Infectious Diseases|March 8, 2014
A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody responseKawsar R Talaat, Catherine J Luke, Surender Khurana, et al.Pediatric Blood & Cancer|July 22, 2009
Lymphocytic vasculitis involving the central nervous system occurs in patients with X-linked lymphoproliferative disease in the absence of Epstein-Barr virus infectionKawsar R Talaat, Jennifer A Rothman, Jeffrey I Cohen, et al.Influenza and Other Respiratory Viruses|March 16, 2012
An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adultsKawsar R Talaat, Ruth A Karron, Philana H Liang, et al.Microorganisms|April 27, 2024
Validation of a Human Challenge Model Using an LT-Expressing Enterotoxigenic <i>E. coli</i> Strain (LSN03-016011) and Characterization of Potential Amelioration of Disease by an Investigational Oral Vaccine Candidate (VLA1701)Kawsar R Talaat, Chad K Porter, Subhra Chakraborty, et al.Journal of Immunological Methods|June 22, 2025
Development of an enteric pathogen multiplex immunoassay to measure antibody responses in blood and saliva for integrated serology applicationsLindsay N Avolio, Nora Pisanic, Kate L Kruczynski, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 16, 2020
The Immunoglobulin M-Shed Acute Phase Antigen (SAPA)-test for the Early Diagnosis of Congenital Chagas Disease in the Time of the Elimination Goal of Mother-to-Child TransmissionYagahira E Castro-Sesquen, Freddy Tinajeros, Caryn Bern, et al.Vaccine|December 11, 2025
Immunogenicity of mRNA COVID-19 vaccine with either simultaneous or sequentially administered inactivated influenza vaccines: a randomized clinical trialEmmanuel B Walter, Elizabeth P Schlaudecker, Kawsar R Talaat, et al.Frontiers in Cellular and Infection Microbiology|September 17, 2021
Exploring Changes in the Host Gut Microbiota During a Controlled Human Infection Model for <i>Campylobacter jejuni</i>Blake W Stamps, Janelle Kuroiwa, Sandra D Isidean, et al.Science Translational Medicine|April 19, 2016
The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge modelBeth D Kirkpatrick, Stephen S Whitehead, Kristen K Pierce, et al.Plos One|December 2, 2020
Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trialKawsar R Talaat, Chad K Porter, Kayla M Jaep, et al.Pageof 6